127 related articles for article (PubMed ID: 10194840)
1. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs).
Glück R
Vaccine; 1999 Mar; 17(13-14):1782-7. PubMed ID: 10194840
[TBL] [Abstract][Full Text] [Related]
2. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system.
Cryz SJ; Glück R
Dev Biol Stand; 1998; 92():219-23. PubMed ID: 9554278
[TBL] [Abstract][Full Text] [Related]
3. Virosomes as carriers for combined vaccines.
Mengiardi B; Berger R; Just M; Glück R
Vaccine; 1995 Oct; 13(14):1306-15. PubMed ID: 8585285
[TBL] [Abstract][Full Text] [Related]
4. Influenza virosomes as an efficient system for adjuvanted vaccine delivery.
Glück R; Moser C; Metcalfe IC
Expert Opin Biol Ther; 2004 Jul; 4(7):1139-45. PubMed ID: 15268680
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice.
Zurbriggen R; Glück R
Vaccine; 1999 Mar; 17(11-12):1301-5. PubMed ID: 10195764
[TBL] [Abstract][Full Text] [Related]
6. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
Glück R; Wälti E
Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236
[TBL] [Abstract][Full Text] [Related]
7. Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens.
Glück R
Vaccine; 1992; 10(13):915-9. PubMed ID: 1471412
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
[TBL] [Abstract][Full Text] [Related]
9. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulating reconstituted influenza virosomes.
Zurbriggen R
Vaccine; 2003 Feb; 21(9-10):921-4. PubMed ID: 12547603
[TBL] [Abstract][Full Text] [Related]
11. IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization.
Zurbriggen R; Novak-Hofer I; Seelig A; Glück R
Prog Lipid Res; 2000 Jan; 39(1):3-18. PubMed ID: 10729605
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.
Glück R; Metcalfe IC
Vaccine; 2003 Jan; 21(7-8):611-5. PubMed ID: 12531327
[TBL] [Abstract][Full Text] [Related]
13. Inactivated virosome hepatitis A vaccine.
Loutan L; Bovier P; Althaus B; Glück R
Lancet; 1994 Feb; 343(8893):322-4. PubMed ID: 7905144
[TBL] [Abstract][Full Text] [Related]
14. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.
Pöltl-Frank F; Zurbriggen R; Helg A; Stuart F; Robinson J; Glück R; Pluschke G
Clin Exp Immunol; 1999 Sep; 117(3):496-503. PubMed ID: 10469053
[TBL] [Abstract][Full Text] [Related]
15. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.
Schumacher R; Adamina M; Zurbriggen R; Bolli M; Padovan E; Zajac P; Heberer M; Spagnoli GC
Vaccine; 2004 Jan; 22(5-6):714-23. PubMed ID: 14741164
[TBL] [Abstract][Full Text] [Related]
16. Perspectives: towards a peptide-based vaccine against hepatitis C virus.
Hunziker IP; Zurbriggen R; Glueck R; Engler OB; Reichen J; Dai WJ; Pichler WJ; Cerny A
Mol Immunol; 2001 Dec; 38(6):475-84. PubMed ID: 11741697
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
[TBL] [Abstract][Full Text] [Related]
18. Influenza virosomes as a vaccine adjuvant and carrier system.
Moser C; Amacker M; Zurbriggen R
Expert Rev Vaccines; 2011 Apr; 10(4):437-46. PubMed ID: 21506642
[TBL] [Abstract][Full Text] [Related]
19. A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans.
Cryz SJ; Que JU; Glück R
Vaccine; 1996 Oct; 14(14):1381-3. PubMed ID: 9004449
[TBL] [Abstract][Full Text] [Related]
20. Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines.
Joseph A; Louria-Hayon I; Plis-Finarov A; Zeira E; Zakay-Rones Z; Raz E; Hayashi T; Takabayashi K; Barenholz Y; Kedar E
Vaccine; 2002 Sep; 20(27-28):3342-54. PubMed ID: 12213404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
